Dr. Alcaraz Rubio is a consultant in Hematology and Hemotherapy with extensive experience in the field. He is the coordinator of the Hematology department at various private hospitals in the Murcia region and serves as the director of the regenerative therapy unit at La Milagrosa Hospital in Madrid. He completed his doctoral courses and research sufficiency at the University of Murcia. He is an expert in anemia, lymphoproliferative and myeloproliferative syndromes, anticoagulant therapy, and hemostasis disorders.

Dr. Alcaraz Rubio is a member of several prestigious professional organizations, including the Spanish Group of Aggressive Lymphomas and Hematopoietic Therapy (GELTHAMO) and the thromboembolic disease group of SEMES. He is recognized internationally as an authority on the use of plasma growth factors. His affiliations also include membership in the Spanish Society of Hematology, the Spanish Society of Thrombosis and Hemostasis, and the American Society of Hematology. He furthered his expertise as a Fellow in Hematology at the Mayo Clinic in Arizona.

In addition to his clinical work, Dr. Alcaraz Rubio is an active member of the oncohematology expert panel on the North American platform LeadPhysician. He contributes as a weekly columnist on current issues in oncohematology for the SERMO platform, reaching audiences in the USA, Latin America, the United Kingdom, and Spain. He also serves on scientific review committees for prestigious North American journals, including Medical Science Monitor, Medical Basic Research, and Stem Cell Translational Medicine.

Dr. Alcaraz Rubio is the author of the book "Regenerative Medicine and the Secret of Platelet-rich Plasma," published by the Spanish Academic Publishing House. He also holds an academic position as an associate professor at the Faculty of Medicine of the University of San Antonio, Murcia, and is the editor-in-chief of the Hematology International Journal.